Wall Street Analysts See a 26.4% Upside in Pediatrix Medical Group (MD): Can the Stock Really Move This High?

Group 1 - The stock of Pediatrix Medical Group (MD) closed at $13.56, reflecting a 10.7% gain over the past four weeks, with a mean price target of $17.14 indicating a potential upside of 26.4% [1] - The mean estimate consists of seven short-term price targets with a standard deviation of $2.61, where the lowest estimate is $14 (3.2% increase) and the highest is $21 (54.9% increase) [2] - Analysts show strong agreement on the company's ability to report better earnings than previously predicted, which supports the view of potential upside [4][11] Group 2 - The Zacks Consensus Estimate for the current year has increased by 1.1% over the past month, with two estimates revised higher and no negative revisions [12] - MD holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates, indicating strong potential for near-term upside [13] - While the consensus price target may not be entirely reliable, the direction it implies appears to be a good guide for potential price movement [13]